4
Changes in Ownership
Citius Pharmaceuticals, Inc. Filed Acc 0001213900-22-062476
Options or other derivatives
- Director acquired 75,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Holuka Eugene Myron · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-10-04 | Grant or award : show line 1 in the form Options to Purchase Common Stock | +75,000 | 75,000 | D |
Loading xslF345X03/ownership.xml…